TPWA
TXG icon

Twin Peaks Wealth Advisors’s 10x Genomics TXG Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42
Closed -$892 – 2059
2026
Q1 		$892 Buy
+42
New +$840 ﹤0.01% 1926

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Twin Peaks Wealth Advisors's TXG Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 42 shares — an estimated $892 sold.

Twin Peaks Wealth Advisors first reported a position in TXG in Q1 2026 and held it in 1 quarter. The position peaked at $892 in Q1 2026. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 42 10x Genomics shares in Q2 2026, an estimated $892.
  • Twin Peaks Wealth Advisors first reported a position in 10x Genomics in Q1 2026 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's 10x Genomics position peaked at $892 in Q1 2026.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.